Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

Conspiracies might be fun to entertain. But the "big lie" tactic destroys your judgment and credibility. Find out why, and ...

We explain how aluminium went from a luxury metal to a world changing material. In the 1800s it was more expensive than gold. New refining methods dropped the price from $1.200 per kilo to just $1.

“We were able to causally link a specific brain pathway to a ‘brake’ on motivation when individuals face unpleasant tasks in ...

In a world where AI-driven bots can forge documents, create synthetic IDs and spoof biometric data, intentional friction is ...

This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. Belle Lin: Welcome to Tech News Briefing. It's Tuesday, December 23rd. I'm Belle ...

Scientists have uncovered a way to manipulate the pathway in monkey brains that puts the brakes on motivation.

One analyst tracking the biotech upgraded her recommendation on its shares. She now believes that they rate a buy, rather than a hold. 10 stocks we like better than Recursion Pharmaceuticals › An ...

Nvidia Corporation’s 2026 Rubin shift to rack-scale AI boosts inference/training strengthens hyperscaler lock-in, and margins ...

One of the earliest mentions of New Year's resolutions appeared in a Boston newspaper in 1813. But the practice itself can be ...

Artificial intelligence has become almost impossible to avoid, and for many, it's slowly replacing Google and other search engines. But while ChatGPT and its competitors can be useful, it's important ...

Jason Chun is a CNET writer covering a range of topics in tech, home, wellness, finance and streaming services. He is passionate about language and technology, and has been an avid writer/reader of ...